{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:18:40Z","timestamp":1793125120814,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12350-022-03059-5","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T11:44:00Z","timestamp":1657885440000},"page":"2748-2760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement"],"prefix":"10.1016","volume":"29","author":[{"given":"Edward J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cuddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesia","family":"Gallegos-Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riemer H.J.A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-022-03059-5_bib1","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib2","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03059-5_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-022-03059-5_bib4","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC review topic of the week","volume":"75","author":"Hanna","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib5","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.amjmed.2015.05.039","article-title":"Noninvasive identification of ATTRwt cardiac amyloid: The re-emergence of nuclear cardiology","volume":"128","author":"Maurer","year":"2015","journal-title":"Am J Med"},{"key":"10.1007\/s12350-022-03059-5_bib7","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s12350-020-02152-x","article-title":"Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation","volume":"28","author":"Cuscaden","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib8","doi-asserted-by":"crossref","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2020;27:659-673. Erratum in: J Nucl Cardiol 2021;28:1763-67.","DOI":"10.1016\/j.cardfail.2021.06.012"},{"issue":"2","key":"10.1007\/s12350-022-03059-5_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03059-5_bib10","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","article-title":"Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT\/CT","volume":"27","author":"Sperry","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12350-019-01831-8","article-title":"99m Technetium pyrophosphate scintigraphy with cadmium zinc telluride cameras is a highly sensitive and specific imaging modality to diagnose transthyretin cardiac amyloidosis","volume":"27","author":"Flaherty","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/01.CIR.50.3.540","article-title":"A new method for radionuclide imaging of acute myocardial infarction in humans","volume":"50","author":"Parkey","year":"1974","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03059-5_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib14","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03059-5_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cpf.12219","article-title":"Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake","volume":"36","author":"Bach-Gansmo","year":"2016","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1007\/s12350-022-03059-5_bib16","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00259-020-04753-7","article-title":"Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT\/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value","volume":"47","author":"Malka","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-022-03059-5_bib17","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s12350-018-1235-6","article-title":"Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis","volume":"26","author":"Rapezzi","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12931-022-01995-x","article-title":"Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients","volume":"23","author":"Monfort","year":"2022","journal-title":"Respir Res"},{"key":"10.1007\/s12350-022-03059-5_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijcard.2017.10.027","article-title":"Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon","volume":"254","author":"Cappelli","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12350-019-01643-w","article-title":"Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy","volume":"28","author":"Gallini","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","article-title":"Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis","volume":"26","author":"Cappelli","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12350-020-02274-2","article-title":"Quantitation of myocardial 99m Tc-HMDP uptake with new SPECT\/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use?","volume":"29","author":"Bellevre","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03059-5_bib24","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.2967\/jnumed.121.262752","article-title":"Reimbursement approaches for radiopharmaceutical dosimetry: Current status and future opportunities","volume":"62","author":"Graves","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-022-03059-5_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12350-016-0707-9","article-title":"Early-phase myocardial uptake intensity of 99m Tc-HMDP vs 99m Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis","volume":"25","author":"Abulizi","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03059-5_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1007\/s12350-022-03059-5_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid"},{"key":"10.1007\/s12350-022-03059-5_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jcmg.2016.05.007","article-title":"Early phase 99 Tc-HMDP scintigraphy for the diagnosis and typing of cardiac amyloidosis","volume":"10","author":"Galat","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03059-5_bib29","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s12350-017-0894-z","article-title":"Apical sparing pattern of left ventricular myocardial 99m Tc-HMDP uptake in patients with transthyretin cardiac amyloidosis","volume":"25","author":"Van Der Gucht","year":"2018","journal-title":"J Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-022-03059-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123005998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123005998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:12:56Z","timestamp":1761027176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123005998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1071358123005998"],"URL":"https:\/\/doi.org\/10.1007\/s12350-022-03059-5","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-022-03059-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}